SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-13 17:55
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,407 vol 		433,500
Filed 2024-03-13 17:55
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,234 vol 		440,907
Filed 2024-03-13 17:55
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,263.40
-6,118 vol
$46.30 each 		8,398
Filed 2024-03-13 17:54
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,026.85
-1,019 vol
$46.15 each 		14,516
Filed 2024-03-13 17:54
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,242.44
-1,289 vol
$45.96 each 		15,535
Filed 2024-03-13 17:53
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$72,958
+7,407 vol
$9.85 each 		16,824
Filed 2024-03-13 17:53
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,881.40
-215 vol
$45.96 each 		9,417
Filed 2024-03-13 17:52
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,154
+1,234 vol
$9.85 each 		9,632
Filed 2024-03-11 17:07
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,407 vol
Filed 2024-03-11 17:06
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,234 vol
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,263.40
-6,118 vol
$46.30 each
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,026.85
-1,019 vol
$46.15 each
Filed 2024-03-11 17:01
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,242.44
-1,289 vol
$45.96 each
Filed 2024-03-11 17:00
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$72,958
+7,407 vol
$9.85 each
Filed 2024-03-11 16:59
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,881.40
-215 vol
$45.96 each
Filed 2024-03-11 16:58
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,154
+1,234 vol
$9.85 each
Filed 2024-03-11 17:07
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-7,407 vol 		433,500
Filed 2024-03-11 17:06
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-1,234 vol 		440,907
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,263.40
-6,118 vol
$46.30 each 		8,398
Filed 2024-03-11 17:02
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,026.85
-1,019 vol
$46.15 each 		14,516
Filed 2024-03-11 17:01
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,242.44
-1,289 vol
$45.96 each 		15,535
Filed 2024-03-11 17:00
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$72,958
+7,407 vol
$9.85 each 		16,824
Filed 2024-03-11 16:59
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,881.40
-215 vol
$45.96 each 		9,417
Filed 2024-03-11 16:58
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,154
+1,234 vol
$9.85 each 		9,632
Filed 2024-03-11 16:49
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-283,263.40
-6,118 vol
$46.30 each
Filed 2024-03-11 16:49
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-47,026.85
-1,019 vol
$46.15 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-59,242.44
-1,289 vol
$45.96 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$72,958
+7,407 vol
$9.85 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,881.40
-215 vol
$45.96 each
Filed 2024-03-11 16:48
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$12,154
+1,234 vol
$9.85 each
Filed 2024-03-11 15:30
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-283,263.40
-6,118 vol
$46.30 each 		442,141
Filed 2024-03-11 15:30
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-283,263.40
-6,118 vol
$46.30 each
Filed 2024-03-11 15:26
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-47,026.85
-1,019 vol
$46.15 each 		448,259
Filed 2024-03-11 15:26
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-47,026.85
-1,019 vol
$46.15 each
Filed 2024-03-11 15:25
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-59,242.44
-1,289 vol
$45.96 each 		449,278
Filed 2024-03-11 15:25
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-59,242.44
-1,289 vol
$45.96 each
Filed 2024-03-11 15:24
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$72,958
+7,407 vol
$9.85 each 		450,567
Filed 2024-03-11 15:24
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$72,958
+7,407 vol
$9.85 each
Filed 2024-03-11 15:21
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,881.40
-215 vol
$45.96 each 		443,160
Filed 2024-03-11 15:21
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-9,881.40
-215 vol
$45.96 each
Filed 2024-03-11 15:19
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$12,154
+1,234 vol
$9.85 each 		443,375
Filed 2024-03-11 15:19
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$12,154
+1,234 vol
$9.85 each
Filed 2024-01-03 13:24
Tx date 2023-12-29 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-8,398 vol 		8,398
Filed 2023-03-14 16:57
Tx date 2023-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		442,141
Filed 2022-09-02 17:36
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-340,508.80
-8,776 vol
$38.80 each 		16,796
Filed 2022-09-02 17:35
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,334,967.09
-35,103 vol
$38.03 each 		25,572
Filed 2022-09-02 17:34
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-6,121 vol 		60,675
Filed 2022-09-02 17:33
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+50,000 vol 		66,796
Filed 2022-09-02 17:32
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-823,546.64
-21,352 vol
$38.57 each 		16,796
Filed 2022-09-02 17:31
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,572 vol 		38,148
Filed 2022-09-02 17:30
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+5,000 vol 		39,720
Filed 2022-09-02 17:29
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+17,488 vol 		34,720
Filed 2022-09-02 17:26
Tx date 2022-09-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-237,500
-50,000 vol
$4.75 each 		367,141
Filed 2022-09-02 17:22
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-23,750
-5,000 vol
$4.75 each 		417,141
Filed 2022-09-02 17:21
Tx date 2022-08-31 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,692.96
-17,488 vol
$2.67 each 		422,141
Filed 2022-03-14 16:36
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		439,629
Filed 2022-03-08 20:14
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-151,150
-5,000 vol
$30.23 each 		17,232
Filed 2022-03-08 20:13
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-155,250
-5,000 vol
$31.05 each 		22,232
Filed 2022-03-08 20:12
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-150,750
-5,000 vol
$30.15 each 		27,232
Filed 2022-03-08 20:11
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-205,057.60
-6,710 vol
$30.56 each 		32,232
Filed 2022-03-08 20:10
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+6,172 vol 		38,942
Filed 2022-03-08 20:09
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-696 vol 		32,770
Filed 2022-03-08 20:07
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$4,615
+1,234 vol
$3.74 each 		33,466
Filed 2022-03-08 20:05
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-23,083.28
-6,172 vol
$3.74 each 		364,629
Filed 2022-03-08 20:05
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-4,615.16
-1,234 vol
$3.74 each 		370,801
Filed 2021-06-01 18:03
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-54,774.72
-2,912 vol
$18.81 each 		32,232
Filed 2021-06-01 18:01
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-59,345.55
-3,155 vol
$18.81 each 		35,144
Filed 2021-06-01 18:00
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-2,192 vol 		38,299
Filed 2021-06-01 18:00
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$50,018
+13,374 vol
$3.74 each 		40,491
Filed 2021-06-01 17:59
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-2,024 vol 		27,117
Filed 2021-06-01 17:59
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$46,170
+12,345 vol
$3.74 each 		29,141
Filed 2021-06-01 17:58
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-50,018.76
-13,374 vol
$3.74 each 		372,035
Filed 2021-06-01 17:57
Tx date 2021-05-28 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-46,170.30
-12,345 vol
$3.74 each 		385,409
Filed 2021-03-15 16:52
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		397,754
Filed 2020-06-02 20:38
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,630 vol 		16,796
Filed 2020-06-02 20:37
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$30,780
+8,230 vol
$3.74 each 		18,426
Filed 2020-06-02 20:35
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-30,780.20
-8,230 vol
$3.74 each 		332,754
Filed 2020-03-16 16:26
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+65,000 vol 		340,984
Filed 2019-09-20 13:02
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$424,800
+45,000 vol
$9.44 each 		275,984
Filed 2019-09-18 20:24
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$16,096
+4,304 vol
$3.74 each 		10,196
Filed 2019-09-18 20:17
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-1,868 vol 		230,984
Filed 2019-09-18 20:15
Tx date 2019-09-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-16,096.96
-4,304 vol
$3.74 each 		232,852
Filed 2018-03-16
Tx date 2018-03-15 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-1,928 vol 		237,156
Filed 2018-03-16
Tx date 2018-03-15 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-4,330.92
-1,158 vol
$3.74 each 		239,084
Filed 2018-03-16
Tx date 2018-03-15 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$4,330
+1,158 vol
$3.74 each 		5,892
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+55,000 vol 		240,242
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,000 vol 		185,242
Filed 2017-05-16
Tx date 2017-05-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$2,662
+712 vol
$3.74 each 		4,734
Filed 2017-05-16
Tx date 2017-05-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-1,345 vol 		174,242
Filed 2017-05-16
Tx date 2017-05-12 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-2,662.88
-712 vol
$3.74 each 		175,587
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+27,500 vol 		176,299
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		148,799
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+15,000 vol 		128,799
Filed 2015-12-18
Tx date 2015-12-16 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$1,104
+182 vol
$6.07 each 		4,022
Filed 2015-12-18
Tx date 2015-12-16 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-2,494.77
-411 vol
$6.07 each 		113,799
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-3,085 vol 		114,210
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Sherrington, Robin Paul
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$10,822
+1,783 vol
$6.07 each 		3,840